Stock Movers: Medtronic, Fervo, Micron (Podcast)

Medtronic struck a binding ~$700m agreement with Cornerstone Robotics, granting Medtronic distribution rights for Cornerstone’s Sentire surgical system in select ex-US markets. Fervo shares jumped ~15% after reports of a major power-sale deal with Alphabet’s Google from a Utah enhanced geothermal project. Micron slid after a report that it plans to deliver its highest incentive pay to Taiwan-based employees in response to a potential union strike.

Analysis

The most important signal is not the headline deal size; it is that a hyperscaler is willing to underwrite firm, carbon-light baseload power. That makes geothermal less of a technology bet and more of a bankability story, which could matter more for project financing spreads than for near-term revenue; the second-order winners are likely the drilling, grid-interconnect, and power-equipment supply chain, while intermittent clean-power peers could lose share in data-center procurement over the next 6-18 months.

For Medtronic, the market should treat this as cheap robotics optionality rather than a material earnings event. Distribution rights let MDT participate in surgery robotics without absorbing the full R&D and manufacturing burden, which is strategically useful against pure-play incumbents, but the P&L impact is likely negligible until there is evidence of procedure adoption or meaningful attach rates. The real upside is a modest multiple support if investors start viewing MDT as a broader med-tech platform instead of a legacy device company.

Micron’s move looks like labor noise unless it becomes an actual throughput issue. Semiconductor stocks often overreact to wage or union headlines, but the earnings driver remains memory pricing and capex discipline; the only reason to care here is if higher incentive pay becomes a Taiwan-wide precedent or if there is any shipment delay that shows up in guidance. Absent that, this is a trading headline, not a thesis change.

Key Decisions for Investors

• Long GOOGL on any post-news weakness over the next 1-3 months; the downside from a single power contract is limited, while the upside is incremental de-risking of AI data-center capacity. Falsify if capex is cut or if management signals power remains a binding constraint.
• Small tactical long FRVO on pullbacks only, with a 1-3 month horizon and a tight risk budget; this is a validation trade, not a full fundamental underwriting. Exit if financing, permitting, or reservoir-performance details fail to appear by the next catalyst window.
• Relative-value long MDT / short ISRG for 3-6 months if the market starts paying up for robotics exposure; MDT is buying optionality with less execution risk and less capital intensity. Falsify if the Sentire channel proves non-exclusive or if robotic utilization data disappoints.
• Do not short MU on this headline alone; wait for actual production disruption or a gross-margin guide-down. If the stock weakens further without operational evidence, treat it as noise and look to cover.